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Abstract
Background: The care of patients with a life-threatening, progressive and far advanced illness in a home-care
setting requires appropriate individual care and requires the active support of family caregivers. General practice
teams are usually the primary care givers and first contact and are best placed to offer support to family caregivers
and to recognise and respond to the burden of care giving on family members. The aim of this project is to
develop a best practice model for engaging with and supporting family caregivers.
Findings: The project is framed as an exploratory trial for a subsequent implementation study, covering phases 0,
I and II of the MRC (Medical Research Council) framework for development, design and evaluation of complex
interventions. The project is a multi-method procedure and has two phases. In the first phase, which has already
been completed, we used a reflective practice procedure where general practice teams were asked about how
they currently deal with family caregivers. In the second phase, a participatory action research approach aims to
improve identification and response to when support is necessary for family caregivers. Ten participating general
practice teams each enrol 40 eligible patients and their family caregiver, to identify structures and tools feasible for
use in their practice. Standardised self-reported questionnaires (Burden Scale for Family Caregivers and Quality of
Life Questionnaire Core 15 Palliative) are being applied at study inclusion (prior to or during the implementation
period) and after 6 and 12 months to explore implementation effects. Qualitative assessment of general practice
teams’ experiences will be triangulated with the quantitative evaluation of the implementation.
Discussion: This two-step approach, which is appropriate to primary palliative care in the German health care
context, will enable general practice teams to develop feasible, acceptable and successful strategies for the
implementation of best practice to successfully support family caregivers of patients at the end of life.
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Findings
Background
The care of patients with a life-threatening, progressive
and end of life illness in a home-care setting requires
appropriate individual patient care and the active support
of family caregivers. In this situation, general practitioners
and practice staff are often the first and continuous health
provider contact for family caregivers. The general prac-
tice team (GPT) therefore plays a pivotal role in the care
of patients at the end of life and in supporting the
patients’ family caregivers. GPTs are not only required to
address the medical needs of patients, but also to recog-
nise and respond appropriately to the physical and psy-
chosocial burden of family caregivers [1], minimize
unnecessary hospital admissions of the patients and there-
fore foster a higher quality of life for patients and their
family caregivers as defined by the World Health Organ-
isation [2].
As in other European countries, most patients in Ger-
many (67 to 90%) wish to die at home [3-5]; although,
in reality, a hospital is the most common site of death
[5-7]. Hospital admissions are common in the last days
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of life [8,9], often because family caregivers feel unable
to cope with the situation and do not receive appropri-
ate professional help [10].
In the UK, care at home is supported by the govern-
ment [11] since it enables patients to maintain an indi-
vidual lifestyle and improves their quality of life [12].
Factors influencing the place of care at the end of life in-
clude family/social support, the preferences of patients
and contacts with health care providers [13]. To receive
sufficient support in caring for patients, family caregivers
need to know about patients’ symptoms, available infor-
mation and spiritual support where appropriate [11].
A systematic review summarized studies of interventions
with family caregivers to reduce their burden and found
that evidence was moderate in dementia and weak in
cancer [14]. Furthermore, studies with family caregivers
of dementia patients often introduced an additional pro-
fessional (case manager, coordinator, etc.) for the duration
of the study but these were no longer available after the
cessation of the study (and the associated funding).
In Germany, the burden of, and relief strategies for,
family caregivers has also been studied mainly for care-
givers of dementia patients [15-17]. However, the results
cannot be transferred easily on to family caregivers of
patients with other conditions. Dementia is character-
ized by long-term and slowly progressing functional dis-
ability, whereas health in other diseases, i.e. incurable
cancer, declines rapidly [18], posing other challenges on
family caregivers. In all diseases, different phases of care
are accompanied by different kinds of burden [19,20]. At
the time of diagnosis, family caregivers are concerned
about the new and challenging situation, understanding
the symptoms, and the effects on the patients’, and their
own, life. At the same time, they tend to underestimate
the burden [20]. Issues can include long-term care; for
example limitations on quality of life, financial con-
straints, the need to give up work, and having to engage
with and navigate the health care system. At the end of
life, family caregivers struggle with reacting to the wor-
sening health status of patients, and often experience
anxiety and depression. Finally, the time of bereavement
has its own challenges [20].
General practitioners are perceived as ideal key work-
ers in meeting the support and counselling needs of
family caregivers [21]. As such they and their practice
teams are expected to identify and offer relief to care-
givers as appropriate taking individual characteristics, i.e.
gender, age and other obligations, into account [22].
Family caregivers should be informed about the
options for burden relief, i.e. about support offered about
administrative issues, counselling centres, social services
and home assistance services, to identify and address
early burden relief and therefore to enable and sustain
care at home. Often this information is not forwarded to
family caregivers who need to be pro-active to find out
about such services [23].
In Germany, the guideline “Informal caregivers” was
issued by the German Society for General Practice and
Family Medicine in 2005 [24]. The authors provide a
general information sheet for caregivers, but also make
it clear that information about specific regional services
within reach of caregivers need to be provided by the
practice team. There are no studies examining the
implementation of this guideline in practices.
Internationally there is a need for longitudinal studies
which involve practice teams, patients and caregivers to
support the development of interventions [25] to sustain
or improve the quality of life of patients and family care-
givers and at preventing or delaying hospital admissions
due to overburdened family caregivers [26].
There are international guidelines in structured end-
of-life care which are not easily transferable to the
German health care system. The Gold Standards Frame-
work (GSF) of the UK, for example, requires a nomi-
nated co-ordinator for palliative care within the primary
health care team on a basic level of adoption [27]. Pri-
mary health care teams in the UK comprise several
members with diverse professional backgrounds, i.e. gen-
eral practitioners (GP), district nurses, managers, prac-
tice nurses etc. In Germany, on the other hand, the size
of practices is smaller, with about half of general prac-
tices single-handed (1 GP) with a small team of doctors’
assistants-comparable to a qualification between that of
a health care assistant and practice nurse. Involvement
in patient care depends on the individual additional qua-
lifications staff have achieved, and needs a delegation
of tasks of the employing GP who holds the final med-
ical responsibility and liability. Meeting tasks stipulated
in the GSF focusing on communication and carer sup-
port could be adapted only if such co-ordinator role can
be identified.
Another important aspect of the German situation is
that no financial incentives exist for primary palliative
care. However, there is a specialist-driven development
for special ambulatory palliative medicine (SAPV).
Within SAPV specialists or specialist teams offer support
from one-off consultations to full palliative care [28].
This system targets patients with an incurable, progres-
sive and life-limiting illness who need extensive care
which cover only approx. 10% of patients who are in a
palliative situation [29].
The PalliPA project (Verbesserung der häuslichen Ver-
sorgung von Palliativpatienten durch Unterstützung
pflegender Angehöriger-Improvement of palliative care
at home by supporting family caregivers) focuses on one
aspect of end-of-life care important throughout the care
process: the role of general practice teams in support-
ing family caregivers of patients at the end of life. The
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project is framed as an exploratory trial for a subsequent
implementation study.
Aim and design
In this study, supporting structures and procedures for
palliative care patients and their family caregivers will be
developed and tested in a sample of general practice
teams (GPTs) with a special interest in palliative care.
This is based on the premise that those practice teams
are more highly motivated to identify a gold standard
for palliative care in general practice than a representa-
tive sample.
There are two main issues regarding caregivers in
general practice which are addressed in the study:
(1)What do GPTs do to identify burdened family
caregivers?
(2)How can GPTs support burdened family caregivers?
What options do they have to offer burden relief
and to where can they refer burdened family
caregivers (i.e. offers in the community)?
To enable an evaluation the intervention needs to be
defined sufficiently and developed rigorously. Campbell
et al. recommended a concurrent observation of the first
3 phases of the framework for design and evaluation of
complex interventions [30]. Phases 0 (preclinical/theory)
and I (modelling) are combined with phase II (explora-
tory trial) to understand the problem, the intervention,
and the evaluation [31]. Table 1 and Figure 1 give an
overview over the PalliPA study within this framework.
Phase 0 (‘Why should the intervention work’?): Imple-
mentation studies in general practices show interven-
tions are best adapted if they can easily be integrated
into existing practice procedures, GPTs are motivated
and committed to the implementation, they receive
support and the implementation is evaluated [32]. The
PalliPA project is based on the Scottish Action Research
study for the improvement of cancer patients’ and their
family caregivers’ care [32], the guideline “Informal care-
givers” of the German Society for General Practice and
Family Medicine (DEGAM) [24] and results of needs
assessments [11,15,20,25]. GPTs take part in developing
and implementing interventions. The feasibility and
practicability of the intervention will be evaluated. GPTs
use existing structures and procedures and optimize
them together with a supporting research team. Involv-
ing the GPTs leads to an early recognition of burden in
family caregivers with the chance to offer relief before
the burden develops into a serious problem.
Phase I (‘How does the intervention work’?): In work-
shops, needs and resources of family caregivers are dis-
cussed with GPTs with special emphasis on stages of
care [20] and the socio-demographic background of
caregivers (employment status, age, gender, own disabil-
ities, other persons to care for). Additionally, the
DEGAM guideline [24] provides information to
recognize caregiver burden which has to be contextua-
lised to end-of-life care.
PalliPA-Qualitative
Data assessment
As part of the workshops in phase I, facilitators and
barriers to good palliative care in general practice were
discussed in focus groups with the GPTs. The focus
groups were digitally recorded and transcribed verbatim
for analysis.
Sample and sample size
The sample consisted of GPTs from the federal state of
Baden-Wuerttemberg. GPTs had to currently take care
of palliative patients. Each GP with an additional qualifi-
cation in palliative medicine listed in the directory of the
Association of Statutory Health Insurance Physicians
(Kassenärztliche Vereinigung) was invited to participate.
Invitations were mailed to GPTs in March 2011.
We planned 3 workshops with 5 GPTs each. We con-
ducted 2 workshops in May and June 2011, where infor-
mation on the project was given and the current support
provided for caregivers was discussed in focus groups. 19
GPs and doctor’s assistants participated in 4 focus groups.
In addition, 2 GPs were interviewed via telephone since
they were not able to participate in the workshops.
Data analysis and implication of results
Transcripts of the focus groups are being analysed using
qualitative content analysis [33]. Qualitative content ana-
lysis means an inductive development of categories and
a deductive application of categories, where key issues
are identified, summarized, labelled as codes and sorted
into main and sub-categories. Primarily, improvement
strategies to relief caregiver burden as proposed by the
GPTs were extracted from the transcripts. These were
complemented by results from the literature to create a
comprehensive list of potential interventions in general
practice. In a second meeting with the GPTs in July
2011, as part of the iterative process, preliminary find-
ings of the focus group were presented and discussed.
Based on these findings the development of a first set of
tools to be used in the practices was discussed and
agreed upon. Immediately after this meeting, GPTs
started to include patients and caregivers in a subse-
quent exploratory trial.
In implementation, both the services provided by prac-
tices and the circumstances of patients and caregivers
need to be considered alongside the improvement strat-
egies mentioned in the focus groups. In previous studies,
various facilitators or barriers in the practices were
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Table 1 Phases of the MRC framework [27] in the PalliPA study*
Current study Planned future work
Phase 0 I II III IV
MRC framework description Preclinical or theoretical
(why should this intervention
work?)
Modelling (how does it work?) Exploratory or pilot trial
(optimising trial measures)
Definite randomized
controlled trial
Implementation
PalliPA study context Existing evidence: German
guideline “Informal caregivers”,
results from international
implementation and
intervention studies, results of
caregivers’ needs assessments
Workshops: GPTs are informed
about the existing evidence
and discuss individual strategies
for identifying and relieving
burdened caregivers
Participatory action research:
individual strategies are
implemented in the practices
and refined within a Plan-Do-
Study-Act cycle
Not part of the
PalliPA study
Not part of the
PalliPA study
Estimation of effects on caregivers
and patients as a basis for the
planning of a subsequent trial
* The PalliPA study refers to Phases 0-II.
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identified, i.e. the absence of a nominated contact person
for caregivers or a lack of cooperation with a nursing
service [34]. Supporting or inhibiting factors associated
with caregivers were also identified, i.e. good experiences
with a nursing service [35] or dealing with guilt when
taking respite from patient care [36]. Recognising and
addressing such explicit and implicit resources and bar-
riers are important aspects of preparing and successfully
implementing an intervention [37].
Phase II: In the exploratory trial following the focus
groups interventions are constantly evaluated and refined
within a participatory action research approach [38] to
create a set of relevant, acceptable and feasible tools to
implement in general practice. The participatory action
research approach enables the GPTs to take an active
part in the development of the implementation. Smaller
changes of one’s own choice have a greater chance of
being accomplished than regarding all problems at once.
GPTs can observe changes more easily and are motivated
to try new solutions, to adapt them to their practice rou-
tine [25,32] and to maintain them. GPTs are able to im-
mediately and flexibly react to the implementation into
their existing practice procedures, thus fostering their
motivation to participate and to develop feasible tools
[32].
In September 2011, the Phase I first set of tools was
sent to the GPTs. As a result from the meeting in July
and reports in the literature, it comprised a practice
register of palliative care patients, a master data sheet
for each patient including information on caregivers, a
summary sheet of issues for detecting burden in care-
givers, and a leaflet with local addresses offering support
for patients and caregivers.
Ten GPTs are participating in this phase of implemen-
tation from September 2011 to June 2012 (Figure 1).
Each GPT develops its own individual strategy for iden-
tifying and relieving burdened caregivers. For 6 months
(09/2011 to 03/2012) members of a scientific team from
the University Hospital Heidelberg will support GPTs
by visiting the practices, by discussing implementation
and occurring problems with the GPTs and by adapting
burden relief strategies as necessary. GPTs regularly feed
back on the tools aiming to improve them for wide-
spread use. From April 2012 to June 2012 GPTs will
then be supported only via telephone and only visited as
requested. Another half year later (12/2012) (without
further feedback), the implications of the project are
reflected upon in another focus group which will dis-
cuss: the overall experiences within the project; which
tools are still in use in the practices; and whether
patients and/or caregivers gave any informal feedback
regarding their support.
PalliPA-Quantitative
Data assessment
Accompanying the intervention, a sample of patients
and family caregivers evaluate their quality of life, family
caregiver burden and healthcare costs during develop-
ment (baseline) and implementation (6-month follow-up
and, where possible, 12-month follow-up for long-time
effects). Patients and caregivers are included in the study
between July 2011 and April 2012, with follow-ups
planned between January and October 2012 and July 2012
and April 2013.
Caregiver burden is assessed by the German version of
the Burden Scale for Family Caregivers (BSFC, Grässel
et al. 2003 [39]). Quality of life is assessed by the
German version of the Quality of Life Questionnaire
Core-15 Palliative Care (QLQ-C15-PAL [40]) of the
European Organisation for Research and Treatment of
Cancer. Health care expenditures are assessed using a
standardized questionnaire. All parameters are used for
an estimation of possible effects over time with which
May/June 
2011 
July 
13th 
workshop with 
participating
GPTs
August/
September 
baseline
caregivers and 
patients
baseline
practices
February/ 
March 2012 
follow-up
practices
6 months 
follow-up
caregivers and 
patients
6 months 
follow-up
caregivers and 
patients
August/
September 
follow-up
practices
end of 
2012 
exchange of 
experience 
supported
implementation 
Phase 1 Phase 2
workshops
with focus 
groups 
Phase 2
Figure 1 Timeline of the PalliPA study.
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the sample size of a future controlled study can be
derived.
In the practices direct effects on the practice structure
are measured as well, i.e. the existence of an up-to-date
register with patients and their caregivers, the offer of
home visits to patients and caregivers, and if the practice
informs burdened caregivers about relief options offered
by the community.
Based on the results of both feedback from the GPTs
as well as of the patient and caregiver survey a con-
trolled implementation study will be planned after the
completion of PalliPA in December 2013 (Table 1).
Control group
The quantitative results will be used for estimating the
effects of the intervention on patients and family care-
givers prerequisite for planning and conducting a rando-
mized controlled trial. Because of the longitudinal
design of the PalliPA Quantitative we will be able to
refer to the results of a historical control group to put
the results into a wider context. The evaluation of
PAMINO (PAlliativMedizinische Initiative NOrdbaden)
[41] was conducted between September 2007 and June
2009 with patients with advanced cancer and their fam-
ily caregivers in general practices. The questionnaires
QLQ-C15-PAL and the short version of the BSFC were
applied, which are also used in the PalliPA project.
Sample and sample size
Participatory action research approaches, combined
with an exploratory trial, places high demands on parti-
cipants. Therefore, in PalliPA, 10 practice teams are
developing, implementing and evaluating support tools
in their practice. In each practice, 4 patients with their
family caregivers are included in the exploratory trial
(07/2011 to 12/2012) to estimate effects on patients’
quality of life and family caregiver burden (Figure 1).
Patient-caregiver dyads are informed about the explo-
ratory trial by the GP or the doctor’s assistant. GPTs
include adult outpatients (at least 18 years of age) with
an incurable and life-threatening illness (i.e. cancer, heart
failure, chronic obstructive lung disease, post stroke)
and a family caregiver who mainly supports the patient.
Both have to give their informed and written consent to
participate in a questionnaire study.
Patients or caregivers suffering from dementia are not
included in the study, since they are not able to consent
to study participation at a later disease stage and cannot
give information about their quality of life (by question-
naires). Furthermore, there are comprehensive studies in
supporting caregivers of dementia patients [17]. Insuffi-
cient German language skills in patients and caregivers
also lead to exclusion from the study.
We need a sample size of at least n = 30 patient-
caregiver dyads to be able to estimate effects from an
exploratory trial [42]. Based on our experiences with the
PAMINO evaluation we assume 1 or 2 eligible cancer
patients cared for in a practice during the implementa-
tion period. Cancer patients comprise about 25–30% of
all palliative care patients in general practice in Germany
[43,44]. Therefore, we could assume a further 2 to 4
patients per practice may be recruited. For a sufficient
data base of 30 patients and caregivers at least 40 dyads
should be enrolled in the study to compensate for attri-
tion and missing data. Based on these assumptions we
need to enrol 8 to 10 GPTs with 4 to 5 patient-caregiver
dyads each in the exploratory trial.
Statistical analysis
The primary outcome of the exploratory trial is the
effect of the implemented interventions on caregiver
burden. Results on the BSFC will be compared after the
3 assessments (baseline and 2 follow-ups) using ANOVA
(analysis of variance) with repeated measures if data are
normally distributed. Otherwise, the Friedman test will
be used. Secondary outcomes on the quality of life of
patients will also be analyzed using ANOVA with
repeated measures or Friedman test, respectively. Data
of practice structure will be described as frequencies
and analyzed with the Cochran test. Health care costs
will be described cross-sectionally and longitudinally.
The assessment will show how feasibly these parameters
can be measured in general as well as a first estimate
of expenditure.
Discussion
Quality of care is at its most meaningful when related to
meeting the needs of individual patients [45]. In no con-
text is this more important than during the period of
palliative care. The care of patients with a life-threaten-
ing, progressive and end-of-life illness in a home-care
setting requires appropriate individual patient care and
the active support of family caregivers. However, the
support given to carers is an under-researched area [25].
The PalliPA project focuses on the role and options of
general practice teams in supporting family caregivers
of patients at the end of life in Germany. While there
are international guidelines related to end-of-life care,
including the UK Gold Standards Framework [27], these
are not easily, and should not be automatically, transfer-
able to the German health care system as health care
systems differ substantially regarding many structural
and organisational aspects. Within the stepwise ap-
proach of the PalliPA project, general practice teams will
be supported in the active development of a feasible, ac-
ceptable and successful strategy to support family care-
givers of patients at the end of life. In addition, the
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project is framed as an exploratory trial for a subsequent
implementation study, covering phases 0, I and II of
the MRC (Medical Research Council) framework [31]
for development, design and evaluation of complex
interventions. The strategies developed within the pro-
ject will be appropriate for primary palliative care in
the German health care context and best practice end-
of-life care.
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